Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Revascularization of Stenosed Vessels Using Optimized Treatment of Rejuveinix for Reversing Endothelial Dysfunction (RESTORE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03041259
Recruitment Status : Not yet recruiting
First Posted : February 2, 2017
Last Update Posted : August 9, 2018
Sponsor:
Information provided by (Responsible Party):
Reven Pharmaceuticals, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : January 2022
Estimated Study Completion Date : July 2022